期刊文献+

广西461例青少年肝硬化临床特点和流行病学分析 被引量:1

Epidemiological and clinical features of 461 patients with cirrhosis among young people from Guangxi province
下载PDF
导出
摘要 目的探讨青少年肝硬化患者的临床特点和流行病学特征。方法收集广西地区1995年~2004年12所三甲医院的461例30岁以下肝硬化患者资料进行回顾性分析。结果80.04%患者为男性;2000年~2004年青少年肝硬化构成比较1994年~1999年明显降低;10年内平均住院费用、每日平均费用均有进行性增加趋势,平均住院日逐渐下降;64.86%(299/461)肝硬化病因是乙型肝炎,HBeAg阴性占81.96%(245/299);24.08%病例发生上消化道出血,14.75%发生感染,3.69%发生肝性脑病,1.74%发生肝肾综合征,死亡组较非死亡组肝性脑病和肝。肾综合征发生率高。结论广西近10年青少年肝硬化所占比例有所下降,HBeAg阴性乙肝后肝硬化是广西青少年肝硬化主要类型,上消化道出血是最常见死因,青少年肝硬化死亡病例中肝性脑病和肝肾综合征发生率高。 Objective To investigate the epidemiological and clinical features of patients with cirrhosis among young people. Methods By retrospective analysis, 461 in-patients with cirrhosis who were less than 30 years of age collected from 12 hospitals in Guangxi province from 1995 to 2004 were studied. Results The 80.04% of patients with cirrhosis were male. The constitute ratio of young patients with cirrhosis from 2000 to 2004 was lower than that from 1995 to 1999. There was observed downward trend in average length of stay and upward trend in the average hospital stay cost. Two hundred and ninety-nine cases were determined as posthepatitis B cirrhosis, accounting for 64.86% of the patients. Two hundred and forty five cases were determined as HBeAg negative hepatitis B, accounting for 81.96% of 299 cases. The incidences of complication with cirrhosis that were upper gastrointestinal bleeding, infection, hepatic encephalopathy (HE) and hepatorenal syndrome (HRS) were 24.08% , 14.75% , 3.69% and 1.74% , respectively. The incidences of HE and HRS in group of death were higher than that in group of non-death. Conclusion The proportion of young patients with cirrhosis is declined in Guangxi province from 1995 to 2004. The most common type of posthepatitic cirrhosis is HBeAg negative cirrhosis. The most common cause of death is upper gastrointestinal bleeding. The incidences of HE and HRS are conspicuous in group of death patients with cirrhosis.
出处 《胃肠病学和肝病学杂志》 CAS 2009年第3期218-220,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 肝硬化 并发症 流行病学 Cirrhosis Complication Epidemiology
  • 相关文献

参考文献3

二级参考文献25

  • 1余滨,王夏,韩荣华,陈载超,陈再芳.武汉市近10年1~3岁儿童乙型肝炎疫苗接种率和乙型肝炎病毒表面抗原携带率调查及发病率分析[J].中国计划免疫,2005,11(2):117-119. 被引量:37
  • 2杨晓光,孔灵芝,翟凤英,马冠生,金水高,中国居民营养与健康状况调查技术执行组.中国居民营养与健康状况调查的总体方案[J].中华流行病学杂志,2005,26(7):471-474. 被引量:174
  • 3Yu-Cheng Lin,Shu-Tin Hsiao,Jong-Dar Chen.Sonographic fatty liver and hepatitis B virus carrier status: Synergistic effect on liver damage in Taiwan Residents adults[J].World Journal of Gastroenterology,2007,13(12):1805-1810. 被引量:10
  • 4[5]Dagher L, Patch D, Marley R, et al. Pharmacological treatment of the hepatorenal syndrome in cirrhotic patients. Aliment Pharmacol Ther ,2000,14(5):515-521.
  • 5[6]Hadengue A, Godano A, Moreau R, et al. Benefical effects of the z-day administraction of terlipression in patients with cirrhosis and hepatorenal syndrome. J hepatol, 1998,29(4):565-570.
  • 6[7]Kaffy F, Borderie C, Chagneau C, et al. Octreotide in the treatment of the hepatorenal syndrome in cirrhostic patients. J Hepatol, 1999, 30(1):174.
  • 7[8]Angeli P, Volpin R, Piovan D, et al. Acute effects of the oral administration of midodrine, an alpha - adrenergic agonist, on renal hemodynamic and renal function in cirrhotic patients with ascites. Hepatology,1998,28(4):937-943.
  • 8[9]Roberts LR, Kamath PS. Ascites and hepatorenal syndrome: Pathophysiology and management. Mayo Clin Proc, 1996,71(9):874-881.
  • 9[10]Brensing KA, Textor J, Strunk H, et al. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome. Lancet, 1997, 349(9053):697-698.
  • 10[11]Gentilini P. Hepatorenal syndrome and ascites: A introduction. Liver,1999,19(1suppl):5-14.

共引文献1017

同被引文献19

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部